GlassScriptPhysician profile
Tal Raviv
NPI 1558366682
$88,867.60
in general payments reported to CMS, 2019-2025
27 companies · $5,972 in 2025
The $5,972 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $12K · 2021: $14K · 2022: $11K · 2023: $1,855 · 2024: $15K · 2025: $5,972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $4,397 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $263 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,223.21 |
| Food and Beverage | $4,396.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $262.50 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $64,801.94 | 2019-2025 | One Series Ultra, Baerveldt Glaucoma Implant (250), Amo Phaco Needle |
| Kala Pharmaceuticals, INC. | $8,519.12 | 2019-2021 | |
| Alcon Research LLC | $3,000.00 | 2024 | |
| Ivantis, INC | $2,456.83 | 2019-2021 | |
| Lumenis LTD. | $2,000.00 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $1,354.32 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,256.04 | 2021 | |
| Sun Pharmaceutical Industries INC. | $1,203.50 | 2019-2025 | Cequa, Xelpros |
| Rxsight INC | $991.80 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $811.96 | 2019-2025 | Clareon, Tryptyr, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $361.88 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Eyepoint US, INC. | $250.83 | 2019-2020 | |
| Omeros Corporation | $250.00 | 2019 | |
| Ocular Therapeutix, INC. | $221.16 | 2019-2020 | |
| New World Medical,INC. | $208.09 | 2023-2025 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Cataract Technology INC. | $192.37 | 2023 | |
| Glaukos Corporation | $166.78 | 2024 | Idose |
| Novartis Pharmaceuticals Corporation | $158.24 | 2020-2023 | |
| Johnson & Johnson Vision Care, INC. | $150.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $147.61 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $133.01 | 2022-2024 | Tyrvaya, Ryzumvi |
| Eyevance Pharmaceuticals LLC | $59.02 | 2019-2023 | Flarex |
| Allergan, INC. | $52.96 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $50.08 | 2025 | Acthar |
| Abbvie INC. | $27.19 | 2025 | |
| Shire North American Group INC | $24.86 | 2019 | |
| Dutch Ophthalmic, USA | $18.01 | 2023 | Tissueblue, Eva, Combined Machine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tal Raviv listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.